AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kriangkum, J
Xu, BW
Nagata, LP
Fulton, RE
Suresh, MR
Citation: J. Kriangkum et al., Bispecific and bifunctional single chain recombinant antibodies, BIOMOL ENG, 18(2), 2001, pp. 31-40
Authors:
McQuarrie, SA
Xiao, Z
Miller, GG
Mercer, JR
Suresh, MR
Citation: Sa. Mcquarrie et al., Modern trends in radioimmunotherapy of cancer: pretargeting strategies forthe treatment of ovarian cancer, Q J NUCL M, 45(2), 2001, pp. 160-166
Authors:
Husereau, DR
Suresh, MR
Citation: Dr. Husereau et Mr. Suresh, A general affinity method to purify peroxidase-tagged antibodies, J IMMUNOL M, 249(1-2), 2001, pp. 33-41
Authors:
Cao, Y
Suresh, MR
Citation: Y. Cao et Mr. Suresh, Bispecific MAb aided liposomal drug delivery, J DRUG TAR, 8(4), 2000, pp. 257-266
Authors:
Bhatnagar, PK
Suresh, MR
Citation: Pk. Bhatnagar et Mr. Suresh, Bispecific monoclonal anti-MUC-1 X-anti-peroxidase antibody based breast cancer immunoassay, J TUMOR M, 15(4), 2000, pp. 253-262
Authors:
Van Domselaar, GH
Okarvi, SM
Fanta, M
Suresh, MR
Wishart, DS
Citation: Gh. Van Domselaar et al., Synthesis and 99(m)Tc-labelling of bz-MAG3-triprolinyl-peptides, their radiochemical evaluation and in vitro receptor-binding, J LABEL C R, 43(12), 2000, pp. 1193-1204
Authors:
Long, MC
Nagata, LP
Ludwig, GV
Alvi, AZ
Conley, JD
Bhatti, AR
Suresh, MR
Fulton, RE
Citation: Mc. Long et al., Construction and characterization of monoclonal antibodies against westernequine encephalitis virus, HYBRIDOMA, 19(2), 2000, pp. 121-127
Authors:
Kriangkum, J
Xu, BW
Gervais, C
Paquette, D
Jacobs, FA
Martin, L
Suresh, MR
Citation: J. Kriangkum et al., Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinoma, HYBRIDOMA, 19(1), 2000, pp. 33-41
Authors:
Agudoawu, S
Li, HY
Habeeb, AG
Rao, PNP
Suresh, MR
Knaus, EE
Citation: S. Agudoawu et al., Design and syntheses of methyl 2-methyl-2-[2-(4-benzoyl-5-phenyl-7-halo-2-azabicyclo[4.1.0]hept-3-ene)]acetates: Novel inhibitors of cyclooxygenase-2(COX-2) with analgesic-antiinflammatory activity, DRUG DEV R, 49(2), 2000, pp. 75-84
Authors:
Stenman, UH
Paus, E
Allard, WJ
Andersson, I
Andres, C
Barnett, TR
Becker, C
Belenky, A
Bellanger, L
Pellegrino, CM
Bormer, OP
Davis, G
Dowell, B
Grauer, LS
Jette, DC
Karlsson, B
Kreutz, FT
van der Kwast, TM
Lauren, L
Leinimaa, M
Leinonen, J
Lilja, H
Linton, HJ
Nap, M
Nilsson, O
Ng, PC
Nustad, K
Peter, A
Pettersson, K
Piironen, T
Rapp, J
Rittenhouse, HG
Rye, PD
Seguin, P
Slota, J
Sokoloff, RL
Suresh, MR
Very, DL
Wang, TJ
Wigheden, I
Wolfert, RL
Yeung, KK
Zhang, WM
Zhou, Z
Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12
Authors:
Jette, DC
Kreutz, FT
Suresh, MR
Citation: Dc. Jette et al., Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 24-27
Authors:
Alvi, AZ
Stadnyk, LL
Nagata, LP
Fulton, RE
Bader, DE
Roehrig, JT
Suresh, MR
Citation: Az. Alvi et al., Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus, HYBRIDOMA, 18(5), 1999, pp. 413-421
Authors:
Xu, BW
Kriangkum, J
Nagata, LP
Fulton, RE
Suresh, MR
Citation: Bw. Xu et al., A single chain Fv specific against Western equine encephalitis virus, HYBRIDOMA, 18(4), 1999, pp. 315-323
Risultati:
1-13
|